Drug recall · September 11, 2013
CARBOplatin Injection recall
Why: Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDC 0703-3249-11
- Lots / codes
Lot 31314458B, 31314459B exp.08/14, 31315794 exp. 10/14, 31315982B exp.11/14
- Quantity
- 780 vials
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Nationwide
- Initiated
- August 13, 2013 · Voluntary: Firm initiated
- Classified
- September 3, 2013
- Reported
- September 11, 2013
- Ended
- August 27, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carboplatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.